Bincy Abraham, MD, MS, FACG

Houston Methodist-Weill Cornell

Poster(s):

• P4325 - Real World Characteristics and Treatment Patterns of Patients With Crohn’s Disease (CD) Treated With Risankizumab: A US Claims Database Study
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P4381 - Safety of Long-Term Ozanimod Treatment Up to 5 Years in Patients With Moderately to Severely Active Ulcerative Colitis: An Interim Analysis of the True North Open-Label Extension
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET